Cellnovo Stock

Stocks

CLNV

FR0012633360

Software

Real-time Euronext Paris 5-day change 1st Jan Change
- EUR -.--% Intraday chart for Cellnovo -.--% -

Valuation: Cellnovo

Market Cap 2.44M 2.13M 1.98M 1.82M 3.43M 235M 3.48M 23.6M 9.24M 115M 9.14M 8.95M 397M P/E 2018 *
-0.15x
P/E 2019 * -
Enterprise Value 12.46M 10.92M 10.13M 9.31M 17.55M 1.2B 17.8M 121M 47.25M 588M 46.77M 45.76M 2.03B EV / Sales 2018
8.63x
EV / Sales 2019 * -
Free-Float
99.67%
Yield 2018 *
-
Yield 2019 * -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 2.68M
-0.30%+1.29% - - 21.46B
-0.85%-5.41%-37.94%+15.51% 15.78B
-6.19%-5.21%+16.31%+91.92% 7.83B
-1.97%-6.09%-56.81%-64.91% 7.52B
-5.17%-8.79%-35.49%+209.34% 4.34B
-3.70%-1.22%-35.23%-22.78% 2.34B
-1.14%+0.29%-35.91%-39.48% 1.81B
-0.40%+2.78%+24.88%+76.02% 1.54B
-0.58%+0.21%-1.43%+37.72% 1.38B
Average -1.80%-1.71%-20.20%+37.92% 6.4B
Weighted average by Cap. -1.57%-2.48%-27.34%+33.61%

Financials

2018 2019 *
Net sales 3.32M 2.91M 2.7M 2.48M 4.68M 321M 4.75M 32.19M 12.6M 157M 12.47M 12.2M 542M -
Net income -15.94M -13.97M -12.97M -11.91M -22.45M -1.54B -22.78M -154M -60.45M -753M -59.83M -58.54M -2.6B -
Net Debt 10.02M 8.78M 8.15M 7.49M 14.12M 967M 14.32M 97.12M 38.01M 473M 37.62M 36.81M 1.63B -
Logo Cellnovo
Cellnovo Group SA is a France-based company principally engaged in medical instrument manufacturing . The Company specialized in the development of a mobile system for managing type 1 diabetes. Its apparatus includes a cordless micro-pump (a patch pump), an integrated monitoring device and a cellular handset with touch screen with an embedded blood glucose meter. The Company system enables diabetics to live a normal life whilst closely monitoring their glycaemia, their use of insulin, their activity and their food intake.
Employees
-
  1. Stock Market
  2. Stocks
  3. CLNV Stock